Palonosetron and Clostridium difficile colitis - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Palonosetron?
Palonosetron has active ingredients of palonosetron hydrochloride. Currently, eHealthMe is studying from 5,401 Palonosetron users.
What is Clostridium Difficile Colitis?
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection) is found to be associated with 2,132 drugs and 1,728 conditions by eHealthMe. Currently, we are studying 13,142 people who have Clostridium difficile colitis.
Do you take Palonosetron and have Clostridium difficile colitis?Check whether Clostridium difficile colitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Palonosetron side effects by duration, gender and age:
- Palonosetron side effects (5,401 reports)
Clostridium difficile colitis treatments and more:
- Clostridium difficile colitis (13,142 reports)
All the drugs that are associated with Clostridium difficile colitis:
All the conditions that are associated with Clostridium difficile colitis:
How the study uses the data?
The study uses data from the FDA. It is based on palonosetron hydrochloride (the active ingredients of Palonosetron) and Palonosetron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hyzaar and Zarxio drug interaction - 10 seconds ago
- Prednisolone Acetate and Alanine Aminotransferase Increased - 12 seconds ago
- Palbociclib and Diclofenac Sodium drug interaction - 15 seconds ago
- Mesna and Cleocin drug interaction - 17 seconds ago
- Cystaran and Pantoprazole drug interaction - 26 seconds ago
- Solifenacin Succinate and Dexamethasone drug interaction - 26 seconds ago
- Fluorouracil and Bupivacaine drug interaction - 28 seconds ago
- Xifaxan and Fluid Overload - 30 seconds ago
- Apidra and Quinapril drug interaction - 33 seconds ago
- Ezetimibe and Hypotension Aggravated - 41 seconds ago